Wearable Sensors For Disease-Specific Data Collection In Clinical Trials - A Pharma Approach
Estrel Hall A
14:55 - 15:20
In this talk I will give an overview of our main considerations for choosing and deploying wearable technologies in clinical trials. As an example I will explain how we went about introducing a specific wearable sensor in one of our ongoing Phase II trials, and the impact that this sensor is expected to make in assessing the efficacy of the treatment investigated.
Speaker Biography (Luis Garcia-Gancedo)
Luis Garcia-Gancedo received a MSci in Physics from the University of Oviedo (Spain) and a PhD in Electronic Engineering from the University of Brighton (UK). He joined the Engineering Department at the University of Cambridge in January 2009 as a Research Associate, working on the development of novel point-of-care sensors for disease diagnostics. In October 2010 Luis was awarded a Lectureship in Engineering at Newnham College (University of Cambridge) becoming Director of Studies in Engineering in January 2011.
Luis joined GSK in 2014 and has since been working on the implementation of patient centric technologies in clinical studies.
Company Profile (GSK)
GSK is a British multinational science-led global healthcare company headquartered in Brentford, London. The company researches and develops a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. GSK has a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.